Spiolto Respimat, Inspiolto Respimat
| Dose | Size & Price | Qty |
|---|
| Fact Table | |
|---|---|
| Formula | Combination: Tiotropium bromide (C19H22BrNO4S2) + Olodaterol (C21H26N2O5) |
| License | FDA and EMA approved (2015) |
| Bioavailability | Inhaled; tiotropium ~33%, olodaterol ~30% (systemic) |
| Legal status | Prescription only (Rx) |
| Chemical Name | Tiotropium bromide monohydrate / (R)-4-[1-hydroxy-2-(phenylmethoxy)ethylamino]-2-(hydroxymethyl)phenol |
| Elimination half-life | Tiotropium ~25 hours; Olodaterol ~45 hours |
| Dosage (Strength) | 2.5 mcg tiotropium / 2.5 mcg olodaterol per actuation; 2 inhalations once daily |
| Pregnancy | Limited human data – use if benefit outweighs risk |
| Brands | Stiolto Respimat |
| Protein binding | Tiotropium ~72%; Olodaterol ~60% |
| PubChem CID | Tiotropium: 5487426 / Olodaterol: 115067 |
| MedlinePlus | a615044 |
| ChEBI | Tiotropium: 9543 / Olodaterol: 135847 |
| ATC code | R03AL06 |
| DrugBank | DB01409 (tiotropium) / DB09058 (olodaterol) |
| KEGG | D03158 (tiotropium) / D09598 (olodaterol) |
| Routes of administration | Inhalation (Respimat soft-mist inhaler) |
Stiolto Respimat is a prescription inhaler that combines two medicines to help people with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It is used once a day as a long-term maintenance treatment, not for quick relief. Tiotropium works by relaxing the muscles around the airways, while olodaterol helps open up the airways to make breathing easier.
The standard dosage of Stiolto Respimat is 2 inhalations once daily at the same time each day. Don't take more than 2 inhalations in 24 hours.
Before the first use, the inhaler needs to be primed. Insert the cartridge and prime the device by turning the base until it clicks, opening the cap, and pressing the dose release button while pointing away from the face. Repeat this process 3 more times until there's a visible mist.
When using it daily, the steps involve first holding the inhaler upright with the cap closed. Then, turn the base until it clicks, open the cap, and breathe out slowly. The mouthpiece should be placed between the lips while closing them around it. Next, press the dose release button while taking a slow, deep breath through the mouth. Hold your breath for 10 seconds or as long as comfortable, then breathe out slowly.
After each use, the cap should be closed until the next dose. If the inhaler hasn't been used for more than 3 days, patients need to release 1 puff toward the ground before the next use. If it hasn't been used for more than 21 days, the device needs to be re-primed with 3 puffs.
Stiolto Respimat contains tiotropium bromide and olodaterol as its active ingredients.
Avoid taking or using this medication if any of the following apply:
Common side effects of Stiolto Respimat include:
These side effects are generally mild and may fade as your body adjusts to the medication. If cough, nasal symptoms, or back discomfort persist or become bothersome, let your healthcare provider know. Do not increase your dose on your own if COPD symptoms worsen.
More serious side effects can occur. For example, Stiolto can worsen breathing problems or cause heart-related effects such as fast or irregular heartbeat, chest pain, or increased blood pressure. It may also cause sudden shortness of breath after use, eye problems like acute narrow-angle glaucoma, urinary retention, or changes in blood sugar or potassium levels. Seek emergency care if breathing suddenly worsens, your rescue inhaler does not help, or you develop chest pain, severe eye pain, facial swelling, or difficulty urinating.
What is Stiolto Respimat used for?
Stiolto Respimat is a prescription inhalation spray used long-term to treat chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It helps improve breathing by relaxing airway muscles and keeping airways open but is not used to treat sudden breathing problems or asthma.
How does Stiolto Respimat work?
Stiolto Respimat combines two bronchodilators: tiotropium, a long-acting muscarinic antagonist (LAMA), and olodaterol, a long-acting beta2-agonist (LABA). Together, they relax different muscle receptors in the lungs, improving airflow and reducing COPD symptoms such as shortness of breath.
How should I use Stiolto Respimat?
Use Stiolto Respimat exactly as prescribed, typically as two inhalations once daily at the same time each day. The inhaler delivers medication in a fine mist using the Respimat device, which requires priming before first use and when not used for several days.
Can Stiolto Respimat be used for asthma?
No, Stiolto Respimat is not approved for asthma treatment. It is specifically indicated for COPD and may increase the risk of asthma-related death if used in asthma patients, particularly due to the LABA component.
What are the most common side effects of Stiolto Respimat?
Common side effects may include sore throat, cough, runny nose, dizziness, and back pain. Some people may also experience dry mouth or increased heart rate. If symptoms are severe or don’t go away, contact a healthcare provider.
Are there serious risks associated with Stiolto Respimat?
Yes, serious risks include paradoxical bronchospasm (unexpected tightening of the airways), cardiovascular effects like increased blood pressure or heart palpitations, and hypersensitivity reactions such as rash or swelling. Seek medical help if breathing worsens or if signs of an allergic reaction appear.
Who should not use Stiolto Respimat?
People allergic to tiotropium, olodaterol, or any ingredients in the product should avoid using it. It is also not recommended for individuals with asthma, certain heart conditions, or a history of narrow-angle glaucoma or urinary retention without first consulting a doctor.
Can I use a rescue inhaler with Stiolto Respimat?
Yes, a fast-acting rescue inhaler (like albuterol) can still be used for sudden breathing issues. Stiolto Respimat is not intended to replace a rescue inhaler and should not be used for quick relief of acute symptoms.
How do I store and maintain the Respimat inhaler?
Store Stiolto Respimat at room temperature, away from moisture and heat. The inhaler should be kept with the cap closed when not in use. Each cartridge lasts for 60 puffs (30 doses) and should be discarded three months after inserting it into the inhaler, even if medication remains.
Can Stiolto Respimat be used with other COPD medications?
In some cases, it may be used with other maintenance treatments, but combining it with other LABAs or LAMAs may increase the risk of side effects. Always consult a healthcare provider before adding or changing COPD medications to avoid duplication and interactions.
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (e.g., different shape or color), as trademark laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.